NO20001612L - Oralt preparat - Google Patents

Oralt preparat

Info

Publication number
NO20001612L
NO20001612L NO20001612A NO20001612A NO20001612L NO 20001612 L NO20001612 L NO 20001612L NO 20001612 A NO20001612 A NO 20001612A NO 20001612 A NO20001612 A NO 20001612A NO 20001612 L NO20001612 L NO 20001612L
Authority
NO
Norway
Prior art keywords
oral preparation
oral
preparation
Prior art date
Application number
NO20001612A
Other languages
English (en)
Other versions
NO20001612D0 (no
Inventor
Noritaka Ii
Toshio Murakami
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of NO20001612D0 publication Critical patent/NO20001612D0/no
Publication of NO20001612L publication Critical patent/NO20001612L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1611Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20001612A 1997-09-30 2000-03-28 Oralt preparat NO20001612L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26544197 1997-09-30
PCT/JP1998/004374 WO1999016470A1 (fr) 1997-09-30 1998-09-29 Preparation orale

Publications (2)

Publication Number Publication Date
NO20001612D0 NO20001612D0 (no) 2000-03-28
NO20001612L true NO20001612L (no) 2000-05-30

Family

ID=17417203

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001612A NO20001612L (no) 1997-09-30 2000-03-28 Oralt preparat

Country Status (11)

Country Link
US (1) US20030069213A1 (no)
EP (1) EP1020193A4 (no)
JP (2) JP4346817B2 (no)
KR (1) KR20010030798A (no)
CN (1) CN1152717C (no)
AU (1) AU9187598A (no)
CA (1) CA2305179A1 (no)
NO (1) NO20001612L (no)
RU (1) RU2184570C2 (no)
TW (1) TW537897B (no)
WO (1) WO1999016470A1 (no)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0001315D0 (en) * 2000-01-20 2000-03-08 Novartis Ag Organic compounds
GB0007760D0 (en) * 2000-03-30 2000-05-17 Smithkline Beckman Corp Composition
JP4706096B2 (ja) * 2000-10-23 2011-06-22 大正製薬株式会社 不快な味を呈する塩基性薬物配合製剤
JP3405342B2 (ja) * 2001-09-11 2003-05-12 味の素株式会社 矯味、矯臭物質の付着した粒状物の製造方法
JP4925534B2 (ja) * 2001-09-27 2012-04-25 宗鉄 丁 漢方薬配合チュアブル錠
DE10152973A1 (de) * 2001-10-26 2003-05-08 Boehringer Ingelheim Int Neue trockene und wässrige Epinastin-Sirup-Formulierung
DE10207394B4 (de) * 2002-02-21 2007-03-29 Lts Lohmann Therapie-Systeme Ag Geschmacksmaskierte oblatenförmige Arzneizubereitung
JPWO2003075918A1 (ja) * 2002-03-14 2005-06-30 第一サントリーファーマ株式会社 塩酸ピルジカイニド含有錠剤(湿式)
KR100465537B1 (ko) * 2002-06-05 2005-01-13 경동제약 주식회사 레보설피라이드 액제 조성물
US7638138B2 (en) 2003-02-21 2009-12-29 Translational Research, Ltd. Compositions for nasal administration of pharmaceuticals
US20040180110A1 (en) 2003-03-14 2004-09-16 Atul Mistry Chewing gum and confectionery compositions containing an endothermic agent
CA2519287A1 (en) 2003-03-27 2004-10-14 Bioactis Limited Powder medicine applicator for nasal cavity
US20050137265A1 (en) * 2003-03-31 2005-06-23 Haley Eugene T. Rapidly dissolving metoclopramide solid oral dosage and method thereof
KR100553019B1 (ko) * 2003-06-19 2006-02-16 현대약품공업주식회사 씹어 먹는 파모티딘 정제의 제조방법
WO2005094812A1 (ja) * 2004-04-01 2005-10-13 Ajinomoto Co., Inc. ナテグリニド含有製剤
DK1757293T3 (da) * 2004-05-11 2012-10-22 Daiichi Sankyo Co Ltd Bh4-responsiv hyperphenylalaninæmi-medikamenter
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
US20080287456A1 (en) * 2004-05-28 2008-11-20 Imaginot Pty Ltd Oral Therapeutic Compound Delivery System
WO2005120463A1 (en) * 2004-06-09 2005-12-22 Ranbaxy Laboratories Limited Rapidly disintegrating tablets of risperidone
WO2006016530A1 (ja) 2004-08-10 2006-02-16 Translational Research, Ltd. 速効性でかつ高い吸収性を可能とする経鼻投与用組成物
WO2006046560A1 (ja) * 2004-10-29 2006-05-04 Taiho Pharmaceutical Co., Ltd. プロピベリン含有経口粉粒状製剤及びその製造法
JP4860940B2 (ja) * 2005-04-21 2012-01-25 株式会社 資生堂 イオントフォレーシスによるトラネキサム酸の経皮送達
AU2006317530B2 (en) * 2005-11-28 2011-09-01 Imaginot Pty Ltd Oral therapeutic compound delivery system
UA95093C2 (uk) 2005-12-07 2011-07-11 Нікомед Фарма Ас Спосіб одержання кальцієвмісної сполуки
JP5345273B2 (ja) * 2006-02-14 2013-11-20 小林製薬株式会社 口中清涼化組成物
JP2007217308A (ja) * 2006-02-14 2007-08-30 Kobayashi Pharmaceut Co Ltd 口中清涼化組成物
WO2008078730A1 (ja) 2006-12-26 2008-07-03 Translational Research, Ltd. 経鼻投与用製剤
FR2915658B1 (fr) * 2007-05-02 2013-10-11 Jean Francois Joseph Michel Letavernier Emploi du mannitol pour la modulation des perceptions gustatives et olfactives des aliments,boissons et complements alimentaires
EP2065038A1 (en) 2007-11-30 2009-06-03 Pharnext New therapeutic approaches for treating Charcot-Marie-Tooth disease
KR100846095B1 (ko) * 2008-04-02 2008-07-14 현대약품 주식회사 염산 페닐레프린을 포함하는 약학 조성물
EP2135607A1 (en) 2008-06-18 2009-12-23 Pharnext Combination of pilocarpin and methimazol for treating Charcot-MarieTooth disease and related disorders
JP5309977B2 (ja) * 2008-12-26 2013-10-09 ライオン株式会社 チュアブル錠
JP2012526726A (ja) 2009-05-15 2012-11-01 株式会社新日本科学 薬物動態が改善された鼻腔内用薬学的組成物
US9393241B2 (en) 2009-06-02 2016-07-19 Pharnext Compositions for treating CMT and related disorders
EP2263665A1 (en) * 2009-06-02 2010-12-22 Pharnext New compositions for treating CMT and related disorders
JP5397026B2 (ja) * 2009-06-05 2014-01-22 ゼリア新薬工業株式会社 内用液剤
GB2472327B (en) 2009-07-31 2013-03-13 Shin Nippon Biomedical Lab Ltd Intranasal granisetron and nasal applicator
GB201006218D0 (en) * 2010-04-14 2010-06-02 Ayanda As Composition
BR112013009829A2 (pt) 2010-10-27 2016-07-26 Future Engineering As dispositivo para uma unidade de limpeza para óleo hidráulico e óleo lubrificante
JP6300906B2 (ja) 2013-06-05 2018-03-28 ファーネクストPharnext 併用医薬有効成分(api)用安定性経口液剤
JP2015040206A (ja) * 2013-08-23 2015-03-02 高田製薬株式会社 刺激性(収斂性、酸味、苦み)のある薬物を含有する口腔内速崩壊錠およびその製造方法
JP6883378B2 (ja) * 2014-06-30 2021-06-09 ロート製薬株式会社 外用剤
JP6532153B2 (ja) * 2015-01-30 2019-06-19 ライオン株式会社 内服用錠剤
JP6101831B1 (ja) * 2016-02-15 2017-03-22 物産フードサイエンス株式会社 塩味増強剤
US10383870B2 (en) 2016-06-10 2019-08-20 Pharnext Early treatment of CMT disease
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices
US11666532B2 (en) 2018-01-19 2023-06-06 Hyloris Developments Sa Tranexamic acid oral solution
JP7296198B2 (ja) * 2018-06-15 2023-06-22 小林製薬株式会社 医薬組成物
CN117618581B (zh) * 2023-12-07 2024-04-09 广州金叶健康科技有限公司 一种中药口服液用矫味剂及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2174004B (en) * 1985-04-23 1988-11-30 American Cyanamid Co Pharmaceutical tablet preparations
GB8730011D0 (en) * 1987-12-23 1988-02-03 Smithkline Dauelsberg Pharmaceutical compositions
DE68903605T2 (de) * 1988-05-04 1993-04-01 Smith Kline French Lab Kautablette.
JP2726498B2 (ja) * 1988-06-27 1998-03-11 第一製薬株式会社 経口固形製剤
AU665944B2 (en) * 1991-04-04 1996-01-25 Procter & Gamble Company, The Chewable antacid compositions
CA2110313C (en) * 1992-12-01 2004-10-26 Edward John Roche Pharmaceutical compositions containing a guanidinothiazole compound and antacids
WO1996004888A1 (en) * 1994-08-12 1996-02-22 Applied Analytical Industries, Inc. Oral compositions of h2-antagonists
JP2705787B2 (ja) * 1994-09-30 1998-01-28 山之内製薬株式会社 苦味改善易服用性h▲2▼ブロッカー固形製剤
JPH10273435A (ja) * 1997-01-29 1998-10-13 Fujisawa Pharmaceut Co Ltd 内服用液剤
JP3783993B2 (ja) * 1997-07-24 2006-06-07 エーザイ株式会社 製剤組成物及びその製造方法

Also Published As

Publication number Publication date
NO20001612D0 (no) 2000-03-28
TW537897B (en) 2003-06-21
CN1280506A (zh) 2001-01-17
US20030069213A1 (en) 2003-04-10
JP5097748B2 (ja) 2012-12-12
EP1020193A4 (en) 2006-05-24
KR20010030798A (ko) 2001-04-16
WO1999016470A1 (fr) 1999-04-08
JP4346817B2 (ja) 2009-10-21
CN1152717C (zh) 2004-06-09
RU2184570C2 (ru) 2002-07-10
AU9187598A (en) 1999-04-23
EP1020193A1 (en) 2000-07-19
CA2305179A1 (en) 1999-04-08
JP2009185082A (ja) 2009-08-20

Similar Documents

Publication Publication Date Title
NO20001612L (no) Oralt preparat
NO308394B1 (no) Oralt preparat
ID20233A (id) Komposisi oral
ATE233060T1 (de) Zahnbürste
ATE537728T1 (de) Zahnbürste
ATE231349T1 (de) Zahnbürste
DE69815089D1 (de) Selbstaufrichtende zahnbürste
NO983624D0 (no) Biocid preparat i fast form
MA24473A1 (fr) Formulations
NO20005399L (no) Farmasöytisk preparat
DE59806063D1 (de) Zahnbürste
DE69713171D1 (de) Mundpflegezubereitung
DE69828097D1 (de) Mundpflegezusammensetzung
DE69809270D1 (de) Zahnbürste
ID20466A (id) Komposisi oral
NO995039L (no) Gastrisk bibeholdt farmasoeytisk preparat
FI951155A (fi) Farmaseuttinen valmiste
NO20011313D0 (no) Nytt preparat
NO20011312D0 (no) Nytt preparat
ID23663A (id) Persiapan kaprolaktam
KR980000415U (ko) 치솔
NO986033D0 (no) Medisinsk preparat
KR970015998U (ko) 치솔
KR970020599U (ko) 부착식 칫솔
KR970053294U (ko) 칫솔